在24年内,类风湿性关节炎的骨质疏松症和骨质疏松性骨折的显著减少:单一中心的经验
Peter Oelzner1, Paul-Heinrich Mueller1, Tobias Hoffmann1
1Department of Internal Medicine III, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
RMD open
|August 20, 2024
概括
骨质疏松症和类风湿性关节炎 (RA) 患者的骨折在24年内显著减少. 这种RA骨健康的改善与增加使用生物疗法和减少使用皮质类固醇有关.
科学领域:
- 类风湿病学 类风湿病学
- 骨科 骨科是指骨科的学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性炎症性疾病,与骨质疏松症和骨折的风险增加有关.
- RA 治疗的进步导致了改善疾病控制,可能会影响 RA 相关的骨并发症.
研究的目的:
- 在24年的时间内,调查类风湿性关节炎患者骨质疏松症和骨质疏松性骨折的发生率的变化.
- 评估不断发展的治疗策略,包括生物药物和葡萄皮质类药物,对RA骨健康的影响.
主要方法:
- 从1996年到2019年,对1086名RA患者的数据进行了回顾性分析.
- 根据治疗期,患者被分为两个队列:1996-2004 (n=539) 和2005-2019 (n=547).
- 骨矿物质密度 (BMD) 和骨折数据在队列之间进行了比较;使用线性回归分析了BMD的预测因素.
主要成果:
- 骨质疏松症的患病率显著下降,从第1组的48.4%降至第2组的28.3% (p<0.001).
- 骨质疏松性外周和脊椎骨折也显示显著下降 (11.5%对21%,p<0.001;和6.6%对10.9%,p=0.011,分别).
- 生物制剂治疗显著增加 (5.0%与19.7%,p<0.001),而葡萄糖皮质类药物使用在第2队列下降,与更高的BMD相关联.
结论:
- 在RA患者的骨质疏松症和骨质疏松性骨折的显著减少在24年内被观察到.
- 2005年至2019年间生物疗法的使用增加与骨健康的这一积极趋势有关.
- 通过现代疗法改善RA疾病控制有助于减轻骨并发症.
更多相关视频
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
8.2K
07:32Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
Published on: May 6, 2020
12.0K
相关概念视频
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Changes in the Appendicular Skeleton with Age
1.9K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
1.9K
Fractures: Bone Repair
3.1K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.1K
Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
